Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on STORM RESOURCES LTD. We currently have 23 research reports from 1 professional analysts.
Frequency of research reports
Research reports on
STORM RESOURCES LTD
STORM RESOURCES LTD
Storm Announces Processing Agreement, Capex Acceleration
09 Sep 16
Storm announced a processing arrangement with Spectra, securing 65 mmcf/d of processing capacity at McMahon on favourable terms. Concurrently, it has accelerated its 2016e capex plans and lifted its 2017e growth forecasts. We have increased our 12-month target price to $6.50/sh from $5.25/sh on the maintenance of our prior 2017e EV/DACF target multiple. Decent stock price performance leading up to this announcement, coupled with market expectation that Storm could accelerate its program and its relative trading illiquidity, could see the stock reflect only partially the kind of CFPS uplift we forecast.
ANNOUNCES PROCESSING ARRANGEMENT AT UMBACH AND INCREASED 2017 PRODUCTION GUIDANCE
08 Sep 16
Impact: Positive. This processing arrangement and capex acceleration has 2017e volumes moving higher on $20 mm increase in 2016e capex and unchanged 2017e capital program, with Storm benefitting from reduced (15%-20%) operating costs. This is positive to our estimates, likely driving 2017e CFPS +20% higher. With this deal representing 55% of projected Umbach processing footprint come January 2017e, we view this as a bridge in the medium term as Storm works towards a longer term solution (ie. operated gas plant).
Reports Second Quarter Results
16 Aug 16
Storm reported second quarter financial and operating results that were in line with our and the market’s expectations. The Company has largely reaffirmed its 2H16e guidance and provided a preliminary 2017e outlook that is effectively in line with our prior view. It could accelerate efforts in 2H16e on confirmation of price recovery, and while its 2017e outlook implicitly offers a slightly lower growth target on lower investment than our prior forecast, there should be no surprises to market estimate adjustments on receipt of this report. We have reduced our 12-month target price to $5.25/sh from $5.50/sh on the maintenance of our prior 2017e EV/DACF target multiple.
2Q16e Quarterly Preview
26 Jul 16
Some Recovery on Segmented Cash Flow Generation Over Q1 Though Still Down 56% Y/Y. In aggregate, the Intermediate, Mid, and Small Cap groups are expected to generate 2Q16e cash flow of $1,281 mm, $183 mm, and $53 mm, or $1.517 billion in total, that while depressed relative to the same period last year (~$2.647 billion combined), is up 17% sequentially from the prior quarter, largely on the strength of crude oil price recovery in the period. Severely weak natural gas pricing picture markedly reversed into summer, market likely to ignore financials for natural gas producers and look ahead to winter and formalization of sell-side 2018e estimates in coming months. Spot AECO natural gas prices recently crested C$2.60/mcf, and with a reasonable alignment of previously distressed NE BC Stn2 differentials, augmented by a withdrawal expected next week, view the market psyche as constructive and looking ahead, with the analogy that this market is shaping up to mirror 2012 still holding. That said, with crude oil poised to retest support levels, combined with strong stock price performance broadly observed YTD, we would characterize sentiment as slightly pessimistic in the near-term which could reduce or unwind momentum-based investment strategies that have worked thus far in 2016.
Intermediates, Mid Caps & Small Cap Commodity Price Update
23 Jun 16
With this publication we highlight forecast revisions associated with our commodity price update (Natural Gas Update; Crude Oil Update), reaffirming a view of commodity price recovery in 2017e. In the interim until then, 2016e Canadian oil price realizations are up ~11% in the synthetic and Edmonton Light streams, with heavy WCS crude up ~20% which is amplified by Canadian oilsands output curtailments. While 2016e Canadian natural gas prices are projected to be ~20% lower, we expect much of this effect to be mitigated by strong hedging positions this year, and remain focused on price recovery next year with very strong increases reflected in both the strip and our revised forecast. Overall, broad valuations are flat to slightly higher coming out of this exercise, with oil/ liquids levered entities observing the highest 2017e CFO uptick. We remain constructive on the space, though the market will need to look past a trough of potentially weak pricing this summer.
Reports First Quarter Results, Tempers 2016e Growth Initiatives
13 May 16
Storm reported first quarter financial and operating results that were in line to ahead of expectations. As telegraphed, Storm has formally reduced its capital investment outlook for 2016e once again in light of sustained weak natural gas prices, delaying the construction of its 3rd Umbach compression facility to April 2017e, now offering ~$40 mm capex for 2016e to achieve 15,500-16,000 boe/d and exit the year at 13,000-14,000 boe/d. We continue to believe the market will endorse the Storm business strategy in this cycle, with no changes to our valuation or ranking coming off of this report.
30 Nov 16
Abzena (ABZA): Interim results indicate happy customers (BUY) | Horizonte Minerals* (HZM): Fund raise completed (CORP) | SacOil* (SAC): Half-year trading statement (CORP) | Revolution Bars (RBG): New openings (BUY) | Amino Technologies* (AMO): Multi operator FUSION roll out (CORP)
Small Cap Breakfast
29 Nov 16
Asia Pacific Investment Partner - the research-driven emerging and frontier markets real estate development business intends to float on AIM and conduct a placing in December RM Secured Direct Lending - The secured direct lending fund intends to float on the Main Market on 15 December raising up to £100m Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December. Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.
24 Nov 16
Quixant* (QXT): Gaming gains (CORP) | SCISYS* (SSY): Bringing good news from Germany (CORP) | Hayward Tyler Group*: Contract wins (CORP) | Sound Energy (SOU): TE-7 flow rate and fund raise (BUY) | Water Intelligence* (WATR): Growth and improving returns in a defensive market (CORP) | Imaginatik* (IMTK): Interim trading update (CORP)
Small Cap Breakfast
28 Nov 16
Warpaint London—Schedule one update. Raising £2.5m at 97p. Expected mkt cap £62.6m vs revenues of £22.3m Walls & Futures REIT — Has raised £1m at £1 to acquire, refurbish or develop residential properties in the UK . Due to arrive on ISDX on 29 November Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December. Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.